Coronavirus
)
Employers should ensure that contingency plans are in place. This includes access to reliable information, readily available testing, the capacity to switch to remote work, and access to medical support. Such planning helps ensure both business continuity and workforce safety in the face of potential future waves.
)
If symptoms begin very early, scheduling the test for around day 3–5 of symptom onset is often optimal; if still negative in the presence of high clinical suspicion, repeat testing should be considered.
)
Although these clinical pointers and scoring tools are invaluable, confirmatory testing (e.g., RT-PCR or rapid antigen testing) help steer the diagnosis in the correct direction.
)
Persistent symptoms after recovery, known as ‘long COVID’, can affect both adults and children, although less frequently in the latter. Symptoms like fatigue, brain fog, and joint pain can significantly affect quality of life. Recognizing and supporting those with long COVID is an emerging need for both public health authorities and employers.
)
Health authorities in Asia are raising concerns as Covid-19 cases surge, signaling a renewed wave of infections across the region. In particular, Hong Kong and Singapore—two of Asia’s major financial hubs—are witnessing a sharp rise in cases.
)
Chinese scientists have found a new bat coronavirus Experts caution that this new virus can infect human cells Scientists stress that global health monitoring are key to preventing future outbreaks
)
In Today's DNA, Zee News anchor Sourabh Raaj Jain analysed the alarming situation of coronavirus infection in Singapore and its significance globally.
)
KP.2 has replaced the previously circulating JN.1 variant and is now driving cases in several countries, including the US, UK, and Canada Data from the US Centers for Disease Control and Prevention shows that KP.2 accounted for about 25 % of new sequenced cases in the last weeks of April The symptoms of the new variant typically include a sore throat, runny nose, congestion, tiredness, fevers, headache, muscle pain, and loss of taste or smell
)
The study, which was posted on a preprint website and has not yet undergone peer review, showed that the lungs of older individuals are less susceptible to SARS-CoV-2 and flu virus replication compared to the young.
)
)
)
Apart from its primary effects on respiratory health, recent findings indicate a troubling link between COVID & heightened susceptibility to cardiac complications Reports of cardiac complications and cardiac arrest among young, previously healthy individuals have sparked concern Studies suggest that the virus can induce a cytokine storm — an overactive immune response — resulting in inflammation and organ failure, including the heart
)
Karnataka is grappling with the surge as the total number of active COVID-19 cases reached 1245.
)
While several variants may share traits, some characteristics such as increased transmissibility, severity, and vaccine evasion, can vary The World Health Organization recently classified JN.1 as a variant of interest, distinct from its parent lineage BA.2.86 Vaccination remains a cornerstone in preventing severe illness and hospitalisation, including against emerging variants, say doctors
)
Amid rising Covid-19 cases,Delhi reported its first case of the COVID-19 sub-variant JN.1 on Wednesday.
)
Thenational capital has reported the first case of JN.1 variant of coronavirus.
)
)
The country's overall COVID case tally has now reached 4,50,09,248 (4.50 crore), while the recovery rate remains commendable at 98.81 percent, with 4,44,71,860 (4.44 crore) individuals having recuperated.
)
Kerala reported the highest number of cases in last 24 hours with 128, followed by Karnataka with 96 and Maharashtra with 35. Delhi registered 16 new cases in the same period.
)
COVID-19 Surge In India: Amid the escalating crisis, Noida, in Uttar Pradesh's Gautam Buddh Nagar, reported its first COVID-19 case in several months.
)
India has so far confirmed 21 cases of the JN.1 Covid variant, sparking both attention and concern across the nation The World Health Organization (WHO) recently classified JN.1 as a variant of interest, distinct from its parent lineage BA.2.86 The global health body emphasised that the overall risk posed by JN.1 remains low based on current evidence
)
Trending
- News
- Photos
- Videos
)